Lumosa Therapeutics Co., Ltd. (TPEX:6535)
142.50
-6.00 (-4.04%)
Apr 2, 2026, 1:30 PM CST
-17.63% (1Y)
| Market Cap | 23.87B -37.9% |
| Revenue (ttm) | 35.83M -8.5% |
| Net Income | -340.54M |
| EPS | -2.05 |
| Shares Out | 167.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 134,460 |
| Average Volume | 171,462 |
| Open | 148.50 |
| Previous Close | 148.50 |
| Day's Range | 141.50 - 149.50 |
| 52-Week Range | 122.00 - 329.50 |
| Beta | 0.22 |
| RSI | 38.57 |
| Earnings Date | May 11, 2026 |